Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Roivant, continuing ascent, claims another victory for rare disease drug

Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also be a “best-in-disease” medicine for an inflammatory eye condition, one analyst said.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Wednesday 21 October →